The China Fund, Inc.

The China Fund, Inc. is a closed ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. It invests in the public equity markets of China that includes the People's Republic of China, Hong Kong, and Taiwan. The fund invests in stocks of companies operating across diversified sectors. It employs a combination of fundamental analysis with bottom-up approach and quantitative analysis to create its portfolio. The fund seeks to benchmarks the performance of its portfolio against the MSCI Golden Dragon Index. The China Fund, Inc. was formed on April 28, 1992 and is domiciled in the United States.

The China Fund, Inc. trades as CHN on NYSE. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $28.21M of revenue and $27.23M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

The China Fund, Inc. can be compared against peers such as Blackstone / GSO Senior Floating Rate Term Fund, BNY Mellon High Yield Strategies Fund, North Square Small Cap Value Fund Investor Class Shares, The New Germany Fund, Inc., Voya Infrastructure, Industrials and Materials Fund, Voya Global Advantage and Premium Opportunity Fund.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $175.47M, beta of 0.38, and return on equity of +19.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CHN currently shows total debt of $0 and beta of 0.38. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: N-8F ORDR (2026-03-26 00:00:00), N-8F NTC (2026-03-02 00:00:00), SC 13G (2026-02-17 00:00:00), N-8F (2025-12-19 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.chinafundinc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.